Literature DB >> 7995299

Neuropathology of late cortical cerebellar atrophy in Japan: distribution of cerebellar change on an autopsy case and review of Japanese cases.

K Tsuchiya1, E Ozawa, F Saito, H Irie, T Mizutani.   

Abstract

We report a Japanese autopsy case of late cortical cerebellar atrophy. The patient had showed clinically transient remission during thyrotropin-releasing hormone therapy. Our case suggests that thyrotropin-releasing hormone therapy is worth trying as a treatment of late cortical cerebellar atrophy. Neuropathological examination showed diffuse cerebellar cortical lesions and absence of neuronal loss in the dorsomedial part of the inferior olives. We studied qualitatively the detailed distribution of the cerebellar cortical lesions in 6 sections of the right cerebellum. The cerebellar lesions were more conspicuous in the most lateral hemisphere than in the vermis. We also reviewed 7 Japanese autopsy cases of late cortical cerebellar atrophy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7995299     DOI: 10.1159/000117052

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  3 in total

1.  Characteristic diffusion tensor tractography in multiple system atrophy with predominant cerebellar ataxia and cortical cerebellar atrophy.

Authors:  Yusuke Fukui; Nozomi Hishikawa; Kota Sato; Yumiko Nakano; Ryuta Morihara; Yasuyuki Ohta; Toru Yamashita; Koji Abe
Journal:  J Neurol       Date:  2016-01       Impact factor: 4.849

2.  Genetic Screening for Spinocerebellar Ataxia Genes in a Japanese Single-Hospital Cohort.

Authors:  Ryuji Sakakibara; Fuyuki Tateno; Masahiko Kishi; Yohei Tsuyusaki; Yosuke Aiba; Hitoshi Terada; Tsutomu Inaoka; Setsu Sawai; Satoshi Kuwabara; Fumio Nomura
Journal:  J Mov Disord       Date:  2017-08-08

3.  Neuronal activity and outcomes from thalamic surgery for spinocerebellar ataxia.

Authors:  Takao Hashimoto; Abirami Muralidharan; Kunihiro Yoshida; Tetsuya Goto; Takehiro Yako; Kenneth B Baker; Jerrold L Vitek
Journal:  Ann Clin Transl Neurol       Date:  2017-12-10       Impact factor: 4.511

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.